Clinical Trial Update: A Study on the Safety and Efficacy of TQB3473 Tablets in the Treatment of Persistent or Chronic Primary Immune Thrombocytopenia (ITP) in Adults [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the safety and efficacy of TQB3473 tablets for persistent or chronic primary immune thrombocytopenia in adults; the study is n…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immune Thrombocytopenia

Drugs mentioned

• TQB3473

Snippet

Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Conditions: Primary Immune Thrombocytopenia | Phase 2 | Status: NOT_YET_RECRUITING